Andrew E. Hendifar MD

Dr. Andrew E. Hendifar, MD, is a medical oncologist and physician-scientist at Cedars-Sinai Medical Center in Los Angeles, where he serves as Medical Director of the Pancreatic Cancer Program and leads the Gastrointestinal Oncology Disease Research Group. He specializes in the treatment of gastrointestinal malignancies, including pancreatic and neuroendocrine tumors, and is recognized for his multidisciplinary, patient-centered approach to cancer care.

Dr. Hendifar’s research focuses on developing innovative therapies for pancreatic cancer and related diseases. His work includes leading early-phase and large international clinical trials, exploring novel treatment strategies such as radioimmunotherapy, anti-inflammatory approaches, and targeted therapies based on tumor biology. He is particularly interested in leveraging the metabolic and molecular characteristics of tumors to design more effective, personalized treatments.

In addition to his research and clinical leadership, Dr. Hendifar plays a key role in academic medicine as Director of the Hematology and Oncology Fellowship Program at Cedars-Sinai. He is actively involved in national research collaborations and serves on committees advancing gastrointestinal cancer research and clinical trial development.